Genomma Lab Internacional SAB de CV  

(Public, BMV:LABB)   Watch this stock  
Find more results for Herrera
+0.10 (0.78%)
Nov 27 - Close
BMV data delayed by 20 mins - Disclaimer
Currency in MXN
Range 12.68 - 13.09
52 week 8.75 - 30.55
Open 12.83
Vol / Avg. 1.04M/2.57M
Mkt cap 13.61B
P/E 12.27
Div/yield     -
EPS 1.06
Shares 1.05B
Beta     -
Inst. own     -
Feb 24, 2016
Q4 2015 Genomma Lab Internacional SAB de CV Earnings Release (Estimated) - 3:00PM CST - Add to calendar
Oct 29, 2015
Q3 2015 Genomma Lab Internacional SAB de CV Earnings Call
Oct 28, 2015
Q3 2015 Genomma Lab Internacional SAB de CV Earnings Release
Sep 29, 2015
Genomma Lab Internacional SAB de CV Corporate Analyst Meeting - New York

Key stats and ratios

Q3 (Sep '15) 2014
Net profit margin 6.76% 12.95%
Operating margin 13.70% 21.19%
EBITD margin - 22.04%
Return on average assets 3.14% 6.99%
Return on average equity 6.41% 15.07%
Employees 930 -
CDP Score - -


Edificio Samara Antonio Dovali Jaime no. 70 Piso 2 Colonia Santa Fe
MEXICO, D.F., 01210
+52-55-50810000 (Phone)
+52-55-50810000 (Fax)

Website links


Genomma Lab Internacional SAB de CV is a Mexico-based over-the-counter pharmaceutical (OTC pharmaceutical), generic drugs (GD) and personal care products company. The Company is engaged in the development, distribution and marketing of a range of products within different brands, for such treatments as anti-acne, varicose vein, hair loss, sexual stimulation and influenza; as well as analgesics and antifungals. The Company’s product portfolio includes such brands as Asepxia, Cicatricure, Goicoechea, Bengue, Diabet TX, Genoprazol, Goicotabs, Shot B, SilkaMedic, Siluet 40, Nikzon, X Ray, Next, Touch Me, Lomecan V and QG5, among others. The Company is a parent of a number of controlled entities, which have operations established in Mexico, the United States, Peru, Chile, Ecuador and Honduras, among others. In June 2014, the Company acquired 50% stake in Grupo Comercial e Industrial Marzam SA de CV.

Officers and directors

Rodrigo Alonso Herrera Aspra Chairman of the Board
Age: 45
Maximo Juda Chief Executive Officer
Oscar Villalobos Torres Executive Vice President of Finance and Administration
Age: 43
Claudia Georgina Ortega Vettoretti Executive Vice President of Marketing
Age: 49
Alejandro Baston Patino Executive Vice President of Human Capital and Commercial Expansion
Age: 48
Renata Virginia Herrera Aspra Executive Vice President of Innovation, Development and Purchases
Age: 49
Ramon Neme Sastre Executive Vice President of Institutional Relations
Age: 52
Marco Sparvieri Corporate Vice President of Operations and Commercialization
Marco Francisco Forastieri Munoz Non-Member Secretary of the Board of Directors
Sabrina Lucila Herrera Aspra Director